Sujata Narayanan

2.0k total citations
23 papers, 475 citations indexed

About

Sujata Narayanan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sujata Narayanan has authored 23 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Surgery. Recurrent topics in Sujata Narayanan's work include Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Sujata Narayanan is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Sujata Narayanan collaborates with scholars based in United States, France and Spain. Sujata Narayanan's co-authors include Sandy Srinivas, Pamela L. Kunz, David Feldman, Paul J. Shami, A. Dimitrios Colevas, Dietlind L. Wahner‐Roedler, Richa Sood, Andrew C. Hanson, Eric J. Olson and Laura L. Loehrer and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The American Journal of the Medical Sciences.

In The Last Decade

Sujata Narayanan

23 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sujata Narayanan United States 13 163 159 83 83 74 23 475
Marc Hinterthaner Germany 13 104 0.6× 224 1.4× 188 2.3× 105 1.3× 89 1.2× 38 680
Toshiaki Yoshimoto Japan 13 137 0.8× 123 0.8× 59 0.7× 42 0.5× 194 2.6× 79 454
Philipp Busch Germany 12 271 1.7× 62 0.4× 87 1.0× 72 0.9× 285 3.9× 28 627
Wonjae Cha South Korea 16 92 0.6× 143 0.9× 73 0.9× 142 1.7× 332 4.5× 69 631
Jonathan Frandsen United States 13 55 0.3× 120 0.8× 49 0.6× 62 0.7× 86 1.2× 23 434
P Kassab Brazil 8 121 0.7× 362 2.3× 82 1.0× 70 0.8× 279 3.8× 53 628
Jonathan R. George United States 14 125 0.8× 88 0.6× 55 0.7× 167 2.0× 187 2.5× 28 529
Hatsumi Yamamoto Japan 12 54 0.3× 121 0.8× 171 2.1× 59 0.7× 27 0.4× 29 520
Jingjing Yin China 13 52 0.3× 129 0.8× 141 1.7× 49 0.6× 27 0.4× 55 537
Henrik Arnberg Sweden 12 212 1.3× 143 0.9× 61 0.7× 135 1.6× 74 1.0× 21 595

Countries citing papers authored by Sujata Narayanan

Since Specialization
Citations

This map shows the geographic impact of Sujata Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujata Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujata Narayanan more than expected).

Fields of papers citing papers by Sujata Narayanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujata Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujata Narayanan. The network helps show where Sujata Narayanan may publish in the future.

Co-authorship network of co-authors of Sujata Narayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Sujata Narayanan. A scholar is included among the top collaborators of Sujata Narayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujata Narayanan. Sujata Narayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agarwal, Neeraj, Michael T. Schweizer, Elena Castro, et al.. (2025). MEVROMETOSTAT (PF-06821497) IN COMBINATION WITH ENZALUTAMIDE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE: THE PHASE 3, RANDOMIZED MEVPRO-1 STUDY. Urologic Oncology Seminars and Original Investigations. 43(3). 2–3. 1 indexed citations
2.
3.
4.
Petrylak, Daniel P., Yohann Loriot, David R. Shaffer, et al.. (2021). Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study. Clinical Cancer Research. 27(12). 3360–3369. 54 indexed citations
5.
Halwani, Ahmad, Vikas Patil, Zachary Burningham, et al.. (2019). Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(1). 1.e1–1.e10. 19 indexed citations
6.
Fizazi, Karim, Silke Gillessen, Charles G. Drake, et al.. (2017). A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(15_suppl). TPS5090–TPS5090. 5 indexed citations
7.
Narayanan, Sujata & A. Dimitrios Colevas. (2016). Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer. Current Treatment Options in Oncology. 17(6). 30–30. 25 indexed citations
8.
Šikić, Branimir I., Sujata Narayanan, A. Dimitrios Colevas, et al.. (2016). A first-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers.. Journal of Clinical Oncology. 34(15_suppl). 3019–3019. 27 indexed citations
9.
Narayanan, Sujata & Sandy Srinivas. (2016). Incorporating VEGF-targeted therapy in advanced urothelial cancer. Therapeutic Advances in Medical Oncology. 9(1). 33–45. 16 indexed citations
10.
Narayanan, Sujata, Sandy Srinivas, & David Feldman. (2015). Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy. Nature Reviews Urology. 13(1). 47–60. 66 indexed citations
11.
Narayanan, Sujata & Pamela L. Kunz. (2015). Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors. Journal of the National Comprehensive Cancer Network. 13(1). 109–117. 27 indexed citations
12.
Narayanan, Sujata, Lauren C. Harshman, & Sandy Srinivas. (2015). Second-Line Therapies in Metastatic Urothelial Carcinoma. Hematology/Oncology Clinics of North America. 29(2). 341–359. 5 indexed citations
13.
Narayanan, Sujata & Pamela L. Kunz. (2015). Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors. Hematology/Oncology Clinics of North America. 30(1). 163–177. 18 indexed citations
14.
Srinivas, Sandy, Sujata Narayanan, Lauren C. Harshman, et al.. (2015). Phase II study of pazopanib with weekly paclitaxel in refractory urothelial cancer.. Journal of Clinical Oncology. 33(7_suppl). 294–294. 8 indexed citations
15.
Narayanan, Sujata & Pamela L. Kunz. (2015). Beyond Biologics: Is there a Role for Systemic Cytotoxic Chemotherapy in Neuroendocrine Tumors?. 2(1). 13–20. 1 indexed citations
16.
Narayanan, Sujata & Paul J. Shami. (2011). Treatment of acute lymphoblastic leukemia in adults. Critical Reviews in Oncology/Hematology. 81(1). 94–102. 33 indexed citations
17.
Narayanan, Sujata, et al.. (2010). Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma. The American Journal of the Medical Sciences. 339(6). 580–581. 28 indexed citations
18.
19.
Wahner‐Roedler, Dietlind L., Eric J. Olson, Sujata Narayanan, et al.. (2007). Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome. Gender Medicine. 4(4). 329–338. 82 indexed citations
20.
Sood, Amit, Sujata Narayanan, Dietlind L. Wahner‐Roedler, et al.. (2007). Use of Complementary and Alternative Medicine Treatments by Patients with Obstructive Sleep Apnea Hypopnea Syndrome. Journal of Clinical Sleep Medicine. 3(6). 575–579. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Hinterthaner Breakdown of academic impact, for papers by Toshiaki Yoshimoto Breakdown of academic impact, for papers by Philipp Busch Breakdown of academic impact, for papers by Wonjae Cha Breakdown of academic impact, for papers by Jonathan Frandsen Breakdown of academic impact, for papers by P Kassab Breakdown of academic impact, for papers by Jonathan R. George Breakdown of academic impact, for papers by Hatsumi Yamamoto Breakdown of academic impact, for papers by Jingjing Yin Breakdown of academic impact, for papers by Henrik Arnberg
Rankless by CCL
2026